Cue Health Inc. (HLTH)
| Market Cap | 90.97M |
| Revenue (ttm) | 328.83M |
| Net Income (ttm) | -291.06M |
| Shares Out | 151.62M |
| EPS (ttm) | -1.95 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,981,426 |
| Open | 0.710 |
| Previous Close | 0.715 |
| Day's Range | 0.580 - 0.710 |
| 52-Week Range | 0.580 - 5.470 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 4.69 (+681.67%) |
| Earnings Date | May 10, 2023 |
About HLTH
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analyti... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for HLTH stock is "Buy." The 12-month stock price forecast is $4.69, which is an increase of 681.67% from the latest price.
News
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44th Annual Global He...
Cue Health Reports First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights Reported first quart...
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for...
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with...
Cue Health to Announce First Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10,...
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. ...
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)---- $HLTH #HLTH--The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)---- $HLTH #HLTH--The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm.
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug A...
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022. Recent and Full-Year 20...
Cue Health's New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits....
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc...
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wed...
Cue Health to Participate at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the f...
Cue Health Selected by Minnesota Department of Health to Provide Statewide Telehealth to Treatment Services to all Minnesota Residents at No Cost
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, today announced that it has been selected by Minnesota Department ...
Cue Health Announces Appointment of Josh Ghaim, Ph.D. and Sachin Jain, M.D.
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that Josh Ghaim, Ph.D. and Sach...
Cue Health Reports Third Quarter 2022 Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter of 2022.
Cue Health to Announce Third Quarter 2022 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2022 financial results on Wednesday, Novembe...
Cue Health Partners with Actress Jamie-Lynn Sigler to Raise Awareness of At-Home, Same-Day Test-to-Treatment Platform for COVID-19 and Beyond
Jamie-Lynn Sigler and Cue Health Announce Product Donation to Multiple Sclerosis Association of America SAN DIEGO , Oct. 6, 2022 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a healthcare technology...
Cue Health Appoints Suzanne Stone as New Chief Commercial Officer
SAN DIEGO , Sept. 27, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne Stone as its new Chief Commercial Offi...
Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer
Dr. Tsay Brings Two Decades of Expertise in Clinical Medicine, Research, and Health Technology to Cue SAN DIEGO , Sept. 8, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare tec...
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® Flu Molecular Test
SAN DIEGO , Sept. 1, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of t...
Cue Health to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Morgan Stanley 20th Annual Global Healthcar...
Cue Health Launches Cue Care™ Nationwide to Provide Same-Day, At-Home, Test-to-Treatment Service for COVID-19
SAN DIEGO , Aug. 29, 2022 /PRNewswire/ -- Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced the nationwide launch ...
Cue Health Provides Enhanced Care & Protection for Immunocompromised Populations & Clinical Care Teams at Fresenius Kidney Care
SAN DIEGO , Aug. 24, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced a new collaboration with Fresenius Kidney Care to provide the most ac...